BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30986487)

  • 1. Second Reported Case of Pediatric Bladder Alveolar Soft Part Sarcoma as Secondary Malignancy After Prior Cytotoxic Chemotherapy.
    Penticuff J; McDermott S; Carrasco A; Bowlin P; Lewing K; Koenig JF
    Urology; 2019 Aug; 130():148-150. PubMed ID: 30986487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
    Paoluzzi L; Maki RG
    JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
    Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
    Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
    Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
    Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
    Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
    Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar soft-part sarcoma of the urinary bladder with urethral recurrence: a unique case with emphasis on differential diagnoses and diagnostic utility of an immunohistochemical panel including TFE3.
    Amin MB; Patel RM; Oliveira P; Cabrera R; Carneiro V; Preto M; Balzer B; Folpe AL
    Am J Surg Pathol; 2006 Oct; 30(10):1322-5. PubMed ID: 17001165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.
    Zhao M; Rao Q; Wu C; Zhao Z; He X; Ru G
    Diagn Pathol; 2015 Sep; 10():160. PubMed ID: 26369552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Alveolar Soft Part Sarcoma of Cheek: Report of a Case and Review of the Literature.
    Hirose K; Naniwa K; Usami Y; Kohara M; Uchihashi T; Tanaka S; Yamada S; Iwamoto Y; Murakami S; Oya K; Fukuda Y; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2021 Dec; 15(4):1426-1431. PubMed ID: 33840045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report.
    Roma AA; Yang B; Senior ME; Goldblum JR
    Int J Gynecol Pathol; 2005 Apr; 24(2):131-5. PubMed ID: 15782069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
    Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
    Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar soft part sarcoma presenting with cutaneous metastases: report of a case with immunohistochemical and molecular characterization.
    Moyano S; Aguilera P; Petit A; de Alava E; MascarĂ³ JM; Palou J; Ferrando J; Alos L
    J Am Acad Dermatol; 2009 Jul; 61(1):117-20. PubMed ID: 19539846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Thyroid Gland Alveolar Soft Part Sarcoma.
    Whaley RD; Thompson LDR
    Head Neck Pathol; 2020 Sep; 14(3):701-706. PubMed ID: 31782115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature.
    Joyama S; Ueda T; Shimizu K; Kudawara I; Mano M; Funai H; Takemura K; Yoshikawa H
    Cancer; 1999 Oct; 86(7):1246-50. PubMed ID: 10506710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A PRIMARY BLADDER ALVEOLAR SOFT PART SARCOMA: A CASE REPORT].
    Asano A; Nishikimi T; Morikami H; Ohashi T; Yamauchi Y; Ishida R; Yamada H; Kobayashi H; Tsuduki T
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(1):45-48. PubMed ID: 35046236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pediatric case of Alveolar Soft Part Sarcoma].
    Marchac A; Picard A; Landman-Parker J; Larroquet M; Vazquez MP; Franchi G
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):547-50. PubMed ID: 17964622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
    Su H; Yu C; Ma X; Song Q
    Invest New Drugs; 2021 Oct; 39(5):1411-1418. PubMed ID: 33765213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.